a
Tornier, an orthopedic extremity device manufacturer, has filed for a $205 million IPO, according to a filing with the U.S. Securities and Exchange Commission and industry reports.
Tornier, a Netherlands-based company with U.S. headquarters in Edina, Minn., offers a broad range of joint replacement products including hips, knees, shoulders, ankles and other extremity prostheses.
Tornier has proposed its NASDAQ symbol as TRNX.
Read the U.S. Securities and Exchange Commission filing for Tornier.
Tagged under
© Copyright ASC COMMUNICATIONS 2011. Interested in LINKING to or REPRINTING this content? View our policies here.